Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay

Kazutoyo Miura, Bruce J Swihart, Bingbing Deng, Luwen Zhou, Thao P Pham, Ababacar Diouf, Timothy Burton, Michael P Fay, Carole A Long, Kazutoyo Miura, Bruce J Swihart, Bingbing Deng, Luwen Zhou, Thao P Pham, Ababacar Diouf, Timothy Burton, Michael P Fay, Carole A Long

Abstract

Malaria transmission-blocking vaccines (TBVs) are potentially helpful tools for malaria eradication. The standard membrane-feeding assay (SMFA) is considered one of the "gold standard" assays for TBV development. However, lack of consensus in reporting results from SMFA has made it very challenging to compare results from different studies. Two main readouts, % inhibition in mean oocyst count per mosquito (TRA) and % inhibition in prevalence of infected mosquitoes (TBA), have been used widely. In this study, we statistically modeled the oocyst data in SMFA using data from 105 independent feeding experiments including 9804 mosquitoes. The model was validated using an independent data set that included 10,790 mosquitoes from 110 feeding studies. The model delineates a relationship between TRA, the mean oocyst count in the control mosquitoes (mo-contl), and TBA. While TRA was independent from mo-contl, TBA values changed depending on mo-contl. Regardless of monoclonal or polyclonal antibodies tested, there were strong concordances between observed TBA and predicted TBA based on the model using mo-contl and observed TRA. Simulations showed that SMFA with lower true control means had increased uncertainty in TRA estimates. The strong linkage between TBA, TRA and mo-contl inspired creation of a standardized TBA, a model-based TBA standardized to a target control mean, which allows comparison across multiple feeds regardless of mo-contl. This is the first study showing that the observed TBA can be reasonably predicted by mo-contl and the TRA of the test antibody using independent experimental data. This study indicates that TRA should be used to compare results from multiple feeds with different levels of mo-contl. If a measure of TBA is desired, it is better to report standardized TBA rather than observed TBA. These recommendations support rational comparisons of results from different studies, thus benefiting future TBV development.

Keywords: Malaria; Standard membrane-feeding assay; Transmission-blocking vaccine.

Published by Elsevier Ltd.

Figures

Fig. 1. SMFA with fixed concentration of…
Fig. 1. SMFA with fixed concentration of 4B7 mAb
Total of 104 independent feeding experiments (124 COMs) were performed with 94 μg/ml of 4B7 mAb. The results of % inhibition of mean oocyst intensity (TRA, A) and % inhibition of oocyst prevalence (TBA, B) are shown. One data point with mean oocyst in control (mo-contl) = 0.13 and TRA = TBA =100% is not shown in the figures.
Fig. 2. Validation of the model
Fig. 2. Validation of the model
Independent SMFA data including 10,790 mosquitoes from 110 feeding experiments with 541 COMs were used to validate the model. The mean oocysts (x-axis in a log-scale) and prevalence (y-axis in a linear-scale) from each COM of the validation data were calculated. The data are presented with jittering and alpha blending to show overlapping points. The best-fit line (red) and the 95% prediction region (PR, blue) was estimated from the ZINB model using the model-building data (the red and blue lines are not the best-fit and the 95% PR of the validation data). The 95% PR of the model was calculated assuming 20 mosquitoes were dissected per COM (see supplement for details).
Fig. 3. Concordance between observed TBA and…
Fig. 3. Concordance between observed TBA and model-based TBA
Independent SMFA data sets (validation data) were utilized to determine whether the model could estimate TBA based on the mo-contl and TRA of test samples. Each point represents the observed TBA (x-axis) and Model-based TBA (y-axis) with each point calibrated to the target mt-contl that is equal to the mo-contl of a single test sample. Data from the 4B7 mAb which targets the Pfs25 antigen (A), other mAbs targeting Pfs48/45 or Pfs230 (B) and mouse polyclonal antibodies targeting Pfs25, Pfs48/45, Pfs230, PfHAP2 or AgAPN1 (C) are shown.
Fig. 4. Number of mosquitoes to achieve…
Fig. 4. Number of mosquitoes to achieve the same level of error in TRA estimates
At each level of % inhibition (TRA), the number of mosquitoes that are required to achieve the same level of mean squared error in % inhibition measurement is estimated by simulation. Different colors and symbols represent different levels of TRA (0% to 95% inhibition). The reference condition is a feed where 20 mosquitoes are analyzed in each COM (20 each for control and test) and mt-contl =10.
Fig. 5. Standardized TBA
Fig. 5. Standardized TBA
From the 4B7 mAb data shown in Fig. 1, 17 data points were randomly selected in each specified mo-contl range: mo-contl were less than 6 for “low”; mo-contl were between 6 and 30 for “med”; and mo-contl more than 30 for “high”. Based on the observed TRA, a standardized TBA was estimated assuming mt-contl = 2 (regardless of mo-contl). Unstandardized TBA (A; i.e., observed TBA) and standardized TBA (B) are shown. Both individual data, the best estimate of TBA and the associated 95% confidence intervals of each group are shown. A similar figure using the full set of 4B7 mAb data, not with randomly selected data (n=17 per range in this figure), is shown in the accompanying manuscript [23] with 95% confidence intervals for individual points.

References

    1. [accessed 24 February 2016];World Malaria Report. 2015
    1. malERA Consultative Group on Vaccines A research agenda for malaria eradication: Vaccines. PLoS Med. 2011;8:e1000398.
    1. Nunes JK, Woods C, Carter T, Raphael T, Morin MJ, Diallo D, et al. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward. Vaccine. 2014;32:5531–5539.
    1. Wu Y, Sinden RE, Churcher TS, Tsuboi T, Yusibov V. Development of malaria transmission-blocking vaccines: from concept to product. Adv Parasitol. 2015;89:109–152.
    1. Nikolaeva D, Draper SJ, Biswas S. Toward the development of effective transmission-blocking vaccines for malaria. Expert Rev Vaccines. 2015:1–28.
    1. Sinden RE, Blagborough AM, Churcher T, Ramakrishnan C, Biswas S, Delves MJ. The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium. Trends Parasitol. 2012;28:457–465.
    1. Ruecker A, Mathias DK, Straschil U, Churcher TS, Dinglasan RR, Leroy D, et al. A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. Antimicrob Agents Chemother. 2014;58:7292–7302.
    1. Sanders NG, Sullivan DJ, Mlambo G, Dimopoulos G, Tripathi AK. Gametocytocidal screen identifies novel chemical classes with Plasmodium falciparum transmission blocking activity. PloS one. 2014;9:e105817.
    1. Baragana B, Hallyburton I, Lee MC, Norcross NR, Grimaldi R, Otto TD, et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015;522:315–320.
    1. Stone WJ, Eldering M, van Gemert GJ, Lanke KH, Grignard L, van de Vegte-Bolmer MG, et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays. Sci Rep. 2013;3:3418.
    1. Githeko AK, Brandling-Bennett AD, Beier M, Atieli F, Owaga M, Collins FH. The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg. 1992;86:355–358.
    1. Toure YT, Doumbo O, Toure A, Bagayoko M, Diallo M, Dolo A, et al. Gametocyte infectivity by direct mosquito feeds in an area of seasonal malaria transmission: implications for Bancoumana, Mali as a transmission-blocking vaccine site. Am J Trop Med Hyg. 1998;59:481–486.
    1. Gouagna LC, Yao F, Yameogo B, Dabire RK, Ouedraogo JB. Comparison of field-based xenodiagnosis and direct membrane feeding assays for evaluating host infectiousness to malaria vector Anopheles gambiae. Acta Trop. 2013;130C:131–139.
    1. Billingsley PF, Medley GF, Charlwood D, Sinden RE. Relationship between prevalence and intensity of Plasmodium falciparum infection in natural populations of Anopheles mosquitoes. Am J Trop Med Hyg. 1994;51:260–270.
    1. van der Kolk M, De Vlas SJ, Saul A, van de Vegte-Bolmer M, Eling WM, Sauerwein RW. Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology. 2005;130:13–22.
    1. Miura K, Deng B, Tullo G, Diouf A, Moretz SE, Locke E, et al. Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays. PloS one. 2013;8:e57909.
    1. Li T, Eappen AG, Richman AM, Billingsley PF, Abebe Y, Li M, et al. Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum. Malaria J. 2015;14:150.
    1. Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med. 1991;174:1203–1208.
    1. Carter R, Graves PM, Keister DB, Quakyi IA. Properties of epitopes of Pfs48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol. 1990;12:587–603.
    1. Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol. 1987;139:4213–4217.
    1. Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, et al. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay. Infect Immun. 2013;81:4377–4382.
    1. Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, et al. Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. Sci Rep. 2015;5:11193.
    1. Swihart BJ, Fay MP, Miura K. Statistical methods for standardized membrane-feeding assays to measure transmission blocking or reducing activity in malaria. Submitted for publication (accompanying manuscript)
    1. Fay MP. Random marginal agreement coefficients: rethinking the adjustment for chance when measuring agreement. Biostatistics. 2005;6:171–180.
    1. Medley GF, Sinden RE, Fleck S, Billingsley PF, Tirawanchai N, Rodriguez MH. Heterogeneity in patterns of malarial oocyst infections in the mosquito vector. Parasitology. 1993;106:441–449.
    1. Churcher TS, Blagborough AM, Delves M, Ramakrishnan C, Kapulu MC, Williams AR, et al. Measuring the blockade of malaria transmission - An analysis of the standard membrane feeding assay. Int J Parasitol. 2012;42:1037–1044.
    1. Da DF, Churcher TS, Yerbanga RS, Yameogo B, Sangare I, Ouedraogo JB, et al. Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions. Exp Parasitol. 2014;149C:74–83.
    1. Sauerwein RW, Tousema T. Transmission blocking malaria vaccines: Assays and candidates in clinical development. Vaccine. 2015;33:7476–82.
    1. Delves MJ, Sinden RE. A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malar J. 2010;9:35.
    1. Stone WJ, Churcher TS, Graumans W, van Gemert GJ, Vos MW, Lanke KH, et al. A scalable assessment of Plasmodium falciparum transmission in the standard membrane feeding assay using transgenic parasites expressing GFP-luciferase. J Infect Dis. 2014;210:1456–1463.

Source: PubMed

3
Subscribe